Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1994 Sep;120(9):539–544. doi: 10.1007/BF01221031

Competitive nested polymerase chain reaction for quantification of humanMDR1 gene expression

Frank Grünebach 1,✉, Ernst-Ulrich Griese 2, Kurt Schumacher 1
PMCID: PMC12201718  PMID: 7519188

Abstract

Tumor cell resistance to cytotoxic drugs is considered one of the major obstacles to successful chemotherapy. Multidrug resistance (MDR) describes the simultaneous expression of cellular resistance to a wide range of structurally and functionally unrelated drugs. The development of the multidrug resistance phenotype is accompanied by multiple morphological and biochemical changes: (a) increased glutathione levels in the cytoplasm, (b) modified levels of enzymes in the nucleus, particularly topoisomerase II, (c) increased DNA repair capacity and (d) overexpression of the (human)MDR1 gene encoding a transmembrane efflux pump (P-glycoprotein, gp-170), which leads to decreased intracellular accumulation and therefore to resistance to a variety of cytotoxic drugs. In this report we describe a competitive polymerase chain reaction (PCR) assay for the absolute quantification ofMDR1 mRNA. This assay uses a transcript generatedin vitro as an internal standard which is later coamplified together with theMDR1 cDNA. Both cDNAs exhibit the sameMDR1 primer sites but differ in the length of the amplicon. For a second round of amplification we applied nestedMDR1 primers and were successful in improving the sensitivity of this competitive PCR system. This test for characterizing theMDR1 expression offers high sensitivity and specificity and is therefore of great clinical relevance. It should be useful in improving monitoring and design of chemotherapy.

Key words: MDR1 gene expression, P-glycoprotein, gp-170, Competitive PCR, nested PCR

Abbreviation

PCR

Polymerase chain reaction

MDR

multidrug resistance

References

  1. Becker-André M, Hahlbrock K (1989) Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 17:9437–9446 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BG, Taylor CW, Miller TP, Salmon SE (1989) Drug resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7:415–424 [DOI] [PubMed] [Google Scholar]
  3. Dano K (1973) Active outward transport of daunomycin in resistent Ehrlich ascites tumor cells. Biochim Biophys Acta 3:466–483 [DOI] [PubMed] [Google Scholar]
  4. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265–269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Futscher B, Blake LL, Grogan TM, Dalton WS (1993) Quantitative polymerase chain reaction analysis ofMDR1 mRNA in multiple myeloma cell lines and clinical sepcimens. Anal Biochem 213:414–421 [DOI] [PubMed] [Google Scholar]
  6. Gerlach JH, Kartner N, Bell DR, Ling V (1986) Multidrug resistance. Cancer Surv 5:25–46 [PubMed] [Google Scholar]
  7. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116–124 [DOI] [PubMed] [Google Scholar]
  8. Gottesman M (1993) How cancer cells evade chemotherapy: 16th Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res 53:747–754 [PubMed] [Google Scholar]
  9. Gottesman MM, Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263:12163–12166 [PubMed] [Google Scholar]
  10. Kimmig A, Gekeler V, Neumann M, Frese G, Handgretinger R, Kardos G, Diddens H, Niethammer D (1990) Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res 50:6793–6799 [PubMed] [Google Scholar]
  11. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB (1990) Quantitative analysis ofMDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87:7160–7164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Piatak M, Luk KC, Williams B, Lifson JD (1993) Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 14:70–81 [PubMed] [Google Scholar]
  13. Porter-Jordan K, Rosenberg EI, Keiser JF, Gross JD, Ross AM, Nasim S, Garrett CT (1990) Nested polymerase chain reaction assay for the detection of cytomegalovirus overcomes false positives caused by contamination with fragmented DNA. J Med Virol 30:85–91 [DOI] [PubMed] [Google Scholar]
  14. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY [Google Scholar]
  15. Shen DW, Fojo A, Chin JE, Robinson IB, Richert N, Pastan I, Gottesman MM (1986) Human multidrug-resistant cell lines: increasedMDR1 expression can precede gene amplification. Science 232:643–445 [DOI] [PubMed] [Google Scholar]
  16. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJL (1990) Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 64:864–872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wang AM, Doyle MV, Mark DF (1989) Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86:9717–9721 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES